Cadent Therapeutics is creating breakthrough therapies for neurological and psychiatric conditions. The company is rapidly advancing a pipeline of novel allosteric modulators of ion channels – taking a well-established pharmaceutical approach and stepping out into new territory. Cadent’s first-of-its-kind approach has the potential to bring harmony back to neuronal rhythms, effectively “re-wiring” the brain to treat movement and cognitive disorders. In December 2020 Novartis acquired Cadent for up to $770 million.
Precision Neuroscience Company Cadent Therapeutics Initiates Phase 1 Study of Lead Compound CAD-1883
Cadent Therapeutics Receives Milestone for the Initiation of Phase 1 Clinical Studies
Member count: 11-50
Total raised: $55M
Founded date: 2017
Investors 1
| Date | Name | Website |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 29.04.2020 | Series B | $15M | - | citybizlis... |
| 15.11.2018 | Series B | $40M | - | citybizlis... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 01.05.2020 | Biopharmac... | Clinical-stage biopharmaceutic... | - | - | pulse2.com... |
| 29.04.2020 | Cadent The... | Cadent Therapeutics, a Cambrid... | USA | - | finsmes.co... |
| 29.04.2020 | Cadent The... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 17.11.2018 | Cadent The... | CAMBRIDGE, MA, Cadent Therap... | - | - | vcnewsdail... |
| 16.11.2018 | Term Sheet... | POWERING A COMEBACK Good morn... | - | - | fortune.co... |
| 15.11.2018 | Cadent The... | CAMBRIDGE, Mass.--(BUSINESS WI... | - | - | citybizlis... |
| 15.11.2018 | Cadent The... | Cadent Therapeutics, a Cambrid... | USA | - | finsmes.co... |